SPRD Bloomberg 3 to12 Month T Bill ETF (BILS) News

Lmao at the inordinate amount of your time you spend posting on a board about a ceo you don't like . You must be in 20/30s age bracket

I think pizza boy needs to stop worrying about what shareholders are invested in. Don’t you agree?
MAJORITY HOLDING STRONG$$

Lets see if he files on time...

Has IHUB become AFFU PR hub?

Buying 500 isn’t desperate, selling 25000 of the weasels shares at the bid just to keep the close below .08 is.

Securities designated UNS only do not enter the grace period when they become delinquent, they move directly to the Expert Market

https://www.otcmarkets.com/files/15c2-11%20Tier%20Chart.pdf

https://photos.app.goo.gl/aTpEA78jhUAYreAT9


https://www.

$BTC $$$$ BOTTOM IN ACCORDING TO THIS CHARTIST CHECK THIS OUT.
https://www.tradingview.com/chart/BTCUSD/HuGpzZfQ-BITCOIN-Cycle-pattern-completed-Year-end-Target-locked-at-150k/

**Super Happy BirthDay, TreeMan** .. !!

...No name, but "Slippery Sandra" wasn't fired. She quit from FHFA. Pulte did say it was a severance package for the eight month period.

Maybe snaggle tooth Stacey Abrams? She was a Biden insider, and knew enough to swindle $$ from fake EPA endorsement. (Sorry that I was passing judge

I have mentioned it before. If you have the best product to realize that it is not surprising that LWLG is shorted and bashed so much. I am sure that everything is done to destroy LWLG, no matter how much it costs. The fear of the competition is very big!! Can you imagine that all other manufacturer

mRNA maybe considered a dirty word but trump is very much invested in it for Cancer. The real question for glioblastoma only, does NWBO truly have edge? We have to assume so but if they don't , establishment is very keen on mRNA.
https://www.dailymail.co.uk/health/article-14322495/cancer-vacc

PR 
https://www.businesswire.com/news/home/20250318296115/en/Exxe-Group-Advances-Tech-Enabled-Real-Estate-Monetization-Frankfurt-Deal

Reallly???

Posting a $300 single trade on the day update on a dead stock???

PATHETIC!!!

 Button closing in T minus 12 days .....

I JUST paid for BOTH documents.

EXTREMELY valuable information.

***** NEW *****

PURDUE PHARMA L.P. et al v ELITE LABORATORIES INC, et al.

Tuesday, March 18, 2025

https://www.pacermonitor.com/case/51356241/PURDUE_PHARMA_LP

Why can't they PR the highlights of the 10-K along with submitting the 10-K? It would be easier for the investment community to digest. Other companies do this all the time.

This was more of a "rhetorical" question. The answer is they should .

If they partner now, they can afford to start new trials in several indicators.

They are so many ways they can partner, Alz only, EU 50/50 and any way you can think of.

Further a BP partner will help with applications, advertising in different countries as appropriate.

I still firmly believe that nobody borrows money to pay about 4X the current share price of a penny stock three years from now.

Now, if what was being bargained for was shares of LQMT AND something else, then I can see where this might actually be a genuine deal. For example, there is

OTCID New rules into effect July 1, $DBMM is already current with that new Rules, but Imagine if on July 1 they start regulating their market and enforcing supply and demand by eliminating the accumulation of OTC derivatives/short (ie Alpine). Imagine if these bad actors tried to cover before all th

I guess spac deals are only gamble for the big boys....
USAR has as already told nothing in hands but a great marketing 

***** NEW *****

PURDUE PHARMA L.P. et al v ELITE LABORATORIES INC, et al.

Tuesday, March 18, 2025

https://www.pacermonitor.com/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al

March 18, 2025 FINRA now goes after Alpine Securities for stealing more than $54.5m from investors. / US Supreme Court allows FINRA proceedings against Alpine Securities👍️Collateral effects on $DBMM stock coming...Hi Shorties still here ? 🥳
https://franknez.com/finra-now-goes-

Nice try...

https://elitepharma.com/technology-overview/

- "The abuse-deterrent opioid products utilize our patented abuse-deterrent technology that is based on a pharmacological approach."

The Company owns the following patents (as of March 31, 2024):

83,333 OHTL FANS CLONKS and Confirmations

https://investorshub.advfn.com/uimage/uploads/2025/3/19/wbxdlBTC_~_18_CAPT_11pm_83333_wicked_plain.jpg


https://investorshub.advfn.com/uimage/uploads/2025/3/19/rhjcdBTC_~_18_CAPT_11pm_83333_FAN_OHTL_wicked_plain.jpg